Projects per year
Personal profile
Biography
Dr Bosco completed his Bachelor of Medicine and Bachelor of Surgery with Honours in 2002 at the University of New South Wales. From 2007 - 2011 he trained in Clinical Immunology/Allergy and Immunopathology in New South Wales and Victoria, at the Westmead and Royal Melbourne Hospitals.
Since being awarded his Fellowship with the Royal Australasian College of Physicians and Royal College of Pathologists of Australasia in 2011, Dr Bosco has held Clinical Immunology and Allergy consultant positions at both the Royal Victorian Eye and Ear and the Alfred Hospitals. He also works as a consultant Immunologist and Allergist with Epworth Allergy Specialists and as an Immunopathologist with Alfred Pathology. He completed his PhD on the immunoregulatory properties of CD52 at the Walter Eliza Hall Institute of Medical Research.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Autoantibody-associated autoimmune disease
- Allergic disease
- Immunodeficiency
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Quantification of antibody levels to SARS-CoV-2 in immunoglobulin replacement therapy products, and their capacity to augment immunity in immunodeficient patients.
Edwards, E. (Primary Chief Investigator (PCI)), van Zelm, M. (Chief Investigator (CI)), Ojaimi, S. (Chief Investigator (CI)), Bosco, J. J. (Chief Investigator (CI)), O'Hehir, R. (Associate Investigator (AI)), Drummer, H. (Associate Investigator (AI)), Hogarth, M. (Associate Investigator (AI)), Daly, J. (Associate Investigator (AI)) & Murphy, J. (Associate Investigator (AI))
Allergy and Immunology Foundation of Australasia
1/10/22 → 30/11/25
Project: Research
-
PROPHECY: Profiling immune RespOnses in Paediatric and High risk populations to SARS-CoV-2
McMahon, J. (Primary Chief Investigator (PCI)), van Zelm, M. (Chief Investigator (CI)), Khoury, G. (Chief Investigator (CI)), Drummer, H. (Chief Investigator (CI)), Mulley, W. (Chief Investigator (CI)), Holland, A. (Chief Investigator (CI)), Woolley, I. (Chief Investigator (CI)), Ojaimi, S. (Chief Investigator (CI)), Rogers, B. (Chief Investigator (CI)), Hoi, A. (Chief Investigator (CI)), Trauer, J. (Chief Investigator (CI)), Sparrow, M. (Chief Investigator (CI)), Licciardi, P. V. (Chief Investigator (CI)), Giles, E. (Chief Investigator (CI)), Curtis, D. (Chief Investigator (CI)), Crawford, N. (Associate Investigator (AI)), Leech, M. (Associate Investigator (AI)), Westall, G. (Associate Investigator (AI)), O'Hehir, R. (Associate Investigator (AI)), Jones, A. (Associate Investigator (AI)), Morand, E. (Associate Investigator (AI)), Bosco, J. J. (Associate Investigator (AI)) & Turner, S. (Associate Investigator (AI))
Monash University, Alfred Health, Monash Health, Murdoch Children's Research Institute, Burnet Institute (Australia), Spleen Australia, National Association of People with HIV Australia (NAPWHA) Incorporated, Musculoskeletal Australia , Safer Care Victoria (SCV)
1/06/22 → 30/05/26
Project: Research
-
Development and standardization of assays for the functional validation of genetic variants in inborn errors of immunity
Edwards, E. (Primary Chief Investigator (PCI)), Bosco, J. J. (Associate Investigator (AI)), Ojaimi, S. (Associate Investigator (AI)), Fok, J. (Associate Investigator (AI)), Wong, N. (Associate Investigator (AI)), van Zelm, M. (Associate Investigator (AI)) & Hambleton, S. (Associate Investigator (AI))
17/04/23 → 16/04/25
Project: Research
-
Long term immune function and complication rates after splenic artery emboli zation for blunt abdominal trauma
Clements, W. (Primary Chief Investigator (PCI)), Lukies, M. W. (Associate Investigator (AI)), Kavnoudias, H. (Associate Investigator (AI)), Joseph, T. I. (Associate Investigator (AI)) & Bosco, J. J. (Associate Investigator (AI))
1/07/19 → 31/12/20
Project: Research
-
Establishing a Jeffrey Modell Center in Melbourne, Australia.
van Zelm, M. (Primary Chief Investigator (PCI)), Choo, S. (Chief Investigator (CI)), Bosco, J. J. (Chief Investigator (CI)), Slade, C. (Chief Investigator (CI)), Bryant, V. (Chief Investigator (CI)), Ojaimi, S. (Chief Investigator (CI)), Barnes, S. (Chief Investigator (CI)), Holdsworth, S. (Chief Investigator (CI)), Gowdie, P. (Chief Investigator (CI)), Douglass, J. (Chief Investigator (CI)), Unglik, G. (Chief Investigator (CI)), Richards, S. (Chief Investigator (CI)), Smart, J. M. (Chief Investigator (CI)), Mehr, S. (Chief Investigator (CI)), Akikusa, J. D. (Chief Investigator (CI)), Allen, R. (Chief Investigator (CI)), Cole, T. S. (Chief Investigator (CI)), Taranto, M. (Chief Investigator (CI)), Stirling, R. (Chief Investigator (CI)), Cameron, P. U. (Chief Investigator (CI)), O'Hehir, R. (Chief Investigator (CI)), Gugasyan, R. (Chief Investigator (CI)), Masters, S. L. (Chief Investigator (CI)) & Moghaddas, F. (Chief Investigator (CI))
19/10/17 → 19/10/23
Project: Research
-
Dupilumab-associated hypereosinophilia in severe asthma
Strong, A., Lin, T., Sverrild, A., Mackay, A., Lee, J., Zubrinich, C., Pham, J., Bosco, J., Denton, E., Dols, M., Stirling, R. G., Dabscheck, E., Iyer, J., Gillman, A. & Hew, M., 1 Jul 2024, In: ERJ Open Research. 10, 4, 4 p., 00048-2024.Research output: Contribution to journal › Letter › Other › peer-review
Open Access -
Neutropaenia complications from Ocrelizumab and Rituximab treatment
Pang, V., Seery, N., Wesselingh, R., Yeh, W., Zhong, M., Tan, T., Dwyer, C., Nesbitt, C., Rath, L., Perera, D., Bridge, F., Skibina, O., Bosco, J. J., Jokubaitis, V., Marriott, M., Butkueven, H., Van Der Walt, A., Massey, J., Sutton, I. & Monif, M., Jan 2024, In: Multiple Sclerosis and Related Disorders. 81, 6 p., 105147.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Citations (Scopus) -
TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies
Boast, B., Goel, S., González-Granado, L. I., Niemela, J., Stoddard, J., Edwards, E. S. J., Seneviratne, S., Spensberger, D., Quesada-Espinosa, J. F., Allende, L. M., McDonnell, J., Haseley, A., Lesmana, H., Walkiewicz, M. A., Muhammad, E., Bosco, J. J., Fleisher, T. A., Cohen, S., Holland, S. M. & van Zelm, M. C. & 3 others, , Sept 2023, In: The Journal of Allergy and Clinical Immunology. 152, 3, p. 736-747 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access5 Citations (Scopus) -
Immune Function After Splenic Artery Embolization for Blunt Trauma: Long-Term Assessment of CD27+ IgM B-Cell Levels
Lukies, M., Zia, A., Kavnoudias, H., Bosco, J. J., Narita, C., Lee, R., Joseph, T. & Clements, W., May 2022, In: Journal of Vascular and Interventional Radiology. 33, 5, p. 505-509 5 p.Research output: Contribution to journal › Article › Research › peer-review
7 Citations (Scopus) -
Immune function and the role of vaccination after splenic artery embolization for blunt splenic injury
Slater, S. J., Lukies, M., Kavnoudias, H., Zia, A., Lee, R., Bosco, J. J., Joseph, T. & Clements, W., Jan 2022, In: Injury. 53, 1, p. 112-115 4 p.Research output: Contribution to journal › Review Article › Other › peer-review
18 Citations (Scopus)